These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 516002)

  • 1. Effect of thrombin on plasminogen activator release from isolated perfused dog leg.
    Kitaguchi H; Hijikata A; Hirata M
    Thromb Res; 1979; 16(3-4):407-20. PubMed ID: 516002
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of MD-805 on plasminogen activator release by thrombin from isolated perfused dog leg.
    Hijikata-Okunomiya A; Kitaguchi H; Hirata M
    Thromb Res; 1987 Mar; 45(5):699-702. PubMed ID: 3590096
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of proteases on plasminogen activator release from isolated perfused dog leg.
    Hijikata A; Hirata M; Kitaguchi H
    Thromb Res; 1980 Dec 1-15; 20(5-6):521-31. PubMed ID: 7015552
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of plasminogen activator from isolated perfused dog heart.
    Matsubara F; Sueishi K; Ishii Y; Tanaka K
    Thromb Haemost; 1985 Feb; 53(1):126-9. PubMed ID: 4039471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A further study on plasminogen activator release by vasoactive agents in the isolated perfused dog leg.
    Hirata M; Kitaguchi H; Funahara Y
    Kobe J Med Sci; 1980 Jun; 26(2):101-8. PubMed ID: 7190627
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.
    Levin EG; Marzec U; Anderson J; Harker LA
    J Clin Invest; 1984 Dec; 74(6):1988-95. PubMed ID: 6542570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness.
    Wagers SS; Norton RJ; Rinaldi LM; Bates JH; Sobel BE; Irvin CG
    J Clin Invest; 2004 Jul; 114(1):104-11. PubMed ID: 15232617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator release with experimental vasoconstrictions in the isolated perfused dog leg.
    Izaki S
    Kobe J Med Sci; 1978 Mar; 24(1):1-16. PubMed ID: 713439
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of thrombin with platelets: purification of the thrombin substrate.
    Berndt MC; Phillips DR
    Ann N Y Acad Sci; 1981; 370():87-95. PubMed ID: 6943980
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological observations of plasminogen activator release caused by vasoactive agents in isolated perfused pig ears.
    Nakajima K
    Thromb Res; 1983 Jan; 29(2):163-74. PubMed ID: 6189238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of alpha-NAPAP on thrombin-induced release of plasminogen activator.
    Klöcking HP; Hoffmann A; Markwardt F
    Thromb Res; 1988 Oct; 52(1):71-3. PubMed ID: 3201399
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of plasminogen activation and hydrolysis of purified fibrinogen and fibrin by dextran 70.
    Carlin G; Bang NU
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):535-46. PubMed ID: 6160642
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture.
    Levine JD; Harlan JM; Harker LA; Joseph ML; Counts RB
    Blood; 1982 Aug; 60(2):531-4. PubMed ID: 6807373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfused rat hindlegs. A model to study plasminogen activator release.
    Emeis JJ
    Thromb Res; 1983 May; 30(3):195-203. PubMed ID: 6683431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible mechanism of vasoactive agents on plasminogen activator release in isolated perfused pig ears.
    Nakajima K
    Thromb Res; 1983 Jan; 29(2):187-96. PubMed ID: 6682579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental studies of the liberation of plasminogen activator by DDAVP].
    Jablonowski C; Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical comparison of intermittent streptokinase and intermittent streptokinase plasminogen therapy.
    Barlow GH; Kakkar VV; Bentley PG; Chan PS; Jones NA; Mistry FD
    Thromb Res; 1979; 15(1-2):135-42. PubMed ID: 483271
    [No Abstract]   [Full Text] [Related]  

  • 20. The detection and differentiation of fibrinolytic enzymes in bacteria.
    Jeffries L; Buckley DE
    J Appl Bacteriol; 1980 Dec; 49(3):479-92. PubMed ID: 6452435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.